Search
Ulmus rubra pollen
go.drugbank.com/drugs/DB10985ApprovedUlmus rubra pollen allergenic extract is used in allergenic testing.
Bos taurus dander
go.drugbank.com/drugs/DB11020ApprovedBos taurus dander allergenic extract is used in allergenic testing.
Boldo leaf extract
go.drugbank.com/drugs/DB15815ApprovedWithdrawnBoldo leaf extract allergenic extract is used in allergenic testing.
Myristica fragrans fruit
go.drugbank.com/drugs/DB15544ApprovedMyristica fragrans fruit allergenic extract is used in allergenic testing.
Vociprotafib
go.drugbank.com/drugs/DB21559InvestigationalVociprotafib has a monoisotopic molecular weight of 450.16 Da. … Vociprotafib is a small molecule drug. The usage of the INN stem '-protafib' in the name indicates that Vociprotafib is a human protein tyrosine phosphatase (HPTP) inhibitor.
Clofutriben
go.drugbank.com/drugs/DB21636InvestigationalClofutriben has a monoisotopic molecular weight of 424.09 Da. … Clofutriben is a small molecule drug. Clofutriben is under investigation in clinical trial NCT05307328 (SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome).
Mivebresib
go.drugbank.com/drugs/DB21300InvestigationalMivebresib has a monoisotopic molecular weight of 459.11 Da. … Mivebresib is a small molecule drug.
Human Umbilical Cord Mesenchymal Stem Cells
go.drugbank.com/drugs/DB15726InvestigationalThese cells express low levels of major histo-compability complex (MHC) class I, and generally lack MHC class II and its co-stimulatory ligands like CD40, CD80, and CD86. … Currently many companies are creating their own version of these stem cells, one of which is by Aspire, who are creating a version named ACT-20.
Afizagabar
go.drugbank.com/drugs/DB21439InvestigationalAfizagabar has a monoisotopic molecular weight of 365.06 Da. … Afizagabar is a small molecule drug. Afizagabar is under investigation in clinical trial NCT02877615 (Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event).
Categories: GABA-A Receptor AntagonistsBHV-1300
go.drugbank.com/drugs/DB22673InvestigationalBHV-1300 is a IgG<sub>1,2,4</sub> selective degrader being investigated for the treatment of Grave's disease.